Glass House Brands (GLAS) Net Equity Issued and Repurchased (2021 - 2026)
Glass House Brands (GLAS) posted quarterly Net Equity Issued and Repurchased of $22.3 million for Q1 2026, up 104.61% quarter-over-quarter from $10.9 million in Q3 2023.
Glass House Brands (GLAS) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $22.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $22.3 million; the TTM figure through Mar 2026 stood at $33.5 million (changed N/A YoY), while the FY2022 annual figure was $303694.0, down 99.76% from the prior year.
- Net Equity Issued and Repurchased advanced to $22.3 million in Q1 2026 per GLAS's latest filing, from $10.9 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $22.3 million in Q1 2026 and bottomed at -$19.2 million in Q4 2022.
- Historically, Net Equity Issued and Repurchased has averaged $2.9 million across 3 years, with a median of $300000.0 in 2023.
- Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased slumped 4318.51% — and 2023, when it soared 200.31%.
- Glass House Brands' Net Equity Issued and Repurchased stood at -$19.2 million in 2022, then surged by 156.78% to $10.9 million in 2023, then surged by 104.61% to $22.3 million in 2026.
- Business Quant data shows GLAS's Net Equity Issued and Repurchased at $22.3 million in Q1 2026, $10.9 million in Q3 2023, and $300000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Glass House Brands | 866.27 Mn | 847.71 Mn | 15.77 Mn | 4.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.30 Mn |
| Mar 31, 2026 | 22.30 Mn |
| Sep 30, 2023 | 10.90 Mn |
| Sep 30, 2023 | 10.90 Mn |
| Mar 31, 2023 | 300,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | -19.20 Mn |
| Dec 31, 2022 | -19.20 Mn |
| Mar 31, 2022 | 99,898.00 |
| Mar 31, 2022 | 99,898.00 |
| Dec 31, 2021 | 455,054.00 |
| Dec 31, 2021 | 455,054.00 |
| Sep 30, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.00 Mn |